Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aogaichi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Cardiovascular Pharmacology|July 1, 1989
Cifenline in the short-term treatment of patients with ventricular premature complexes: a double-blind placebo-controlled studyJ B Kostis, D Davis, J Kluger, et al.
Journal of Clinical Pharmacology|October 1, 1984
The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dogG Keren, D Tepper, B Butler, et al.
Journal of Clinical Pharmacology|September 1, 1987
Evaluation of dosing interval and optimum dose of cibenzolineP Zempol, K Aogaichi, B Butler, et al.
British Journal of Clinical Pharmacology|April 1, 1991
The effects of cimetidine and ranitidine on the pharmacokinetics of cifenlineJ W Massarella, T M Defeo, J Liguori, et al.
Journal of Clinical Pharmacology|October 1, 1985
Inotropic drugs for the treatment of heart failureD M Mancini, G Keren, K Aogaichi, et al.
American Heart Journal|April 1, 1985
Antiarrhythmic effects of cibenzolineD S Miura, G Keren, V Torres, et al.
American Heart Journal|October 1, 1988
The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardiaC M Pratt, M Francis, S Mahler, et al.
Clinical Pharmacology and Therapeutics|March 1, 1984
Cibenzoline plasma concentration and antiarrhythmic effectR K Brazzell, K Aogaichi, J J Heger, et al.
Journal of Clinical Pharmacology|July 1, 1984
Single-dose pharmacokinetics and dose proportionality of oral cibenzolineK C Khoo, A J Szuna, W A Colburn, et al.
Journal of Clinical Pharmacology|September 1, 1985
Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteersR K Brazzell, K C Khoo, A J Szuna, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Pharmacology|July 1, 1989
Cifenline in the short-term treatment of patients with ventricular premature complexes: a double-blind placebo-controlled studyJ B Kostis, D Davis, J Kluger, et al.
Journal of Clinical Pharmacology|October 1, 1984
The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dogG Keren, D Tepper, B Butler, et al.
Journal of Clinical Pharmacology|September 1, 1987
Evaluation of dosing interval and optimum dose of cibenzolineP Zempol, K Aogaichi, B Butler, et al.
British Journal of Clinical Pharmacology|April 1, 1991
The effects of cimetidine and ranitidine on the pharmacokinetics of cifenlineJ W Massarella, T M Defeo, J Liguori, et al.
Journal of Clinical Pharmacology|October 1, 1985
Inotropic drugs for the treatment of heart failureD M Mancini, G Keren, K Aogaichi, et al.
American Heart Journal|April 1, 1985
Antiarrhythmic effects of cibenzolineD S Miura, G Keren, V Torres, et al.
American Heart Journal|October 1, 1988
The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardiaC M Pratt, M Francis, S Mahler, et al.
Clinical Pharmacology and Therapeutics|March 1, 1984
Cibenzoline plasma concentration and antiarrhythmic effectR K Brazzell, K Aogaichi, J J Heger, et al.
Journal of Clinical Pharmacology|July 1, 1984
Single-dose pharmacokinetics and dose proportionality of oral cibenzolineK C Khoo, A J Szuna, W A Colburn, et al.
Journal of Clinical Pharmacology|September 1, 1985
Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteersR K Brazzell, K C Khoo, A J Szuna, et al.
Pageof 2